Paper9723819
Population pharmacokinetics of ondansetron: a covariate analysis.
de Alwis DP and 2 others. Br J Clin Pharmacol, 1998. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Population pharmacokinetics of ondansetron: a covariate analysis. Papers, record 9723819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9723819
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiemetics | Major topic |
| Ondansetron | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Analysis of Variance | |
| Child | |
| Child, Preschool | |
| Demography | |
| Female | |
| Humans | |
| Male | |
| Metabolic Clearance Rate | |
| Middle Aged | |
| Models, Statistical |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2348382 | Evaluation of population (NONMEM) pharmacokinetic parameter estimates. | J Pharmacokinet Biopharm | 1990 | https://conductscience.org/library/papers/2348382 | PubMed |
| 2 | 8690814 | Pharmacokinetics of ondansetron in patients with hepatic insufficiency. | J Clin Pharmacol | 1996 | https://conductscience.org/library/papers/8690814 | PubMed |
| 3 | 1531044 | Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers. | Clin Pharmacol Ther | 1992 | https://conductscience.org/library/papers/1531044 | PubMed |
| 4 | 1839313 | Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly. | J Pharm Sci | 1991 | https://conductscience.org/library/papers/1839313 | PubMed |
| 5 | 1559308 | Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling. | Clin Pharmacokinet | 1992 | https://conductscience.org/library/papers/1559308 | PubMed |
| 6 | 1587058 | Pharmacokinetics of quinidine in male patients. A population analysis. | Clin Pharmacokinet | 1992 | https://conductscience.org/library/papers/1587058 | PubMed |
| 7 | 1387254 | Ondansetron metabolism and pharmacokinetics. | Semin Oncol | 1992 | https://conductscience.org/library/papers/1387254 | PubMed |
| 8 | 1287200 | Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects. | J Pharmacokinet Biopharm | 1992 | https://conductscience.org/library/papers/1287200 | PubMed |
| 9 | 7691500 | Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. | Drugs | 1993 | https://conductscience.org/library/papers/7691500 | PubMed |
| 10 | 8013282 | The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron. | Drug Metab Dispos | 1994 | https://conductscience.org/library/papers/8013282 | PubMed |
| 11 | 8018461 | The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/8018461 | PubMed |
| 12 | 7929872 | Oral ondansetron pharmacokinetics: the effect of chemotherapy. | J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7929872 | PubMed |
| 13 | 7554705 | Pharmacokinetics of intravenous ondansetron in healthy children undergoing ear, nose, and throat surgery. | Clin Pharmacol Ther | 1995 | https://conductscience.org/library/papers/7554705 | PubMed |
| 14 | 8591723 | Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans. | Drug Metab Dispos | 1995 | https://conductscience.org/library/papers/8591723 | PubMed |
| 15 | 8786955 | Population pharmacokinetic modeling: the importance of informative graphics. | Pharm Res | 1995 | https://conductscience.org/library/papers/8786955 | PubMed |
| 16 | 1920085 | A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam. | J Pharmacokinet Biopharm | 1991 | https://conductscience.org/library/papers/1920085 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32495990 | Plasma and cerebrospinal fluid pharmacokinetics of ondansetron in humans. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/32495990 | PubMed |
| 30976908 | Population pharmacokinetics of palonosetron and model-based assessment of dosing strategies. | J Anesth | 2019 | https://conductscience.org/library/papers/30976908 | PubMed |
| 27195435 | Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/27195435 | PubMed |
| 26558626 | Population pharmacokinetics of ramosetron. | J Pharmacokinet Pharmacodyn | 2016 | https://conductscience.org/library/papers/26558626 | PubMed |
| 19798490 | Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months. | Eur J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/19798490 | PubMed |
| 17324241 | Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients. | Br J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17324241 | PubMed |
| 16675509 | Ondansetron does not reduce the shivering threshold in healthy volunteers. | Br J Anaesth | 2006 | https://conductscience.org/library/papers/16675509 | PubMed |
| 15025739 | Population pharmacokinetics of raltitrexed in patients with advanced solid tumours. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/15025739 | PubMed |
| 14678339 | Population pharmacokinetics of weekly docetaxel in patients with advanced cancer. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14678339 | PubMed |
| 12889740 | Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience. | Invest New Drugs | 2003 | https://conductscience.org/library/papers/12889740 | PubMed |
| 12194534 | Population pharmacokinetic analysis of the major metabolites of capecitabine. | J Pharmacokinet Pharmacodyn | 2002 | https://conductscience.org/library/papers/12194534 | PubMed |
| 11736878 | Population pharmacokinetics of amphotericin B in children with malignant diseases. | Br J Clin Pharmacol | 2001 | https://conductscience.org/library/papers/11736878 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9723819
GET https://conductscience.org/api/papers/v1/9723819/authors